<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE collection SYSTEM "BioC.dtd">
<collection><source>GO_Annotation</source><date>20130316</date><key>go_annotation.key</key><document><id>21680742</id><passage><infon key="type">front</infon><offset>0</offset><annotation id="21680742_1"><infon key="gene">Mhc(35007)</infon><infon key="go-term">ADP binding|GO:0043531</infon><infon key="goevidence">NONE</infon><infon key="type">GOA</infon><location offset="0" length="112"/><text>Two Drosophila Myosin Transducer Mutants with Distinct Cardiomyopathies Have Divergent ADP and Actin Affinities*</text></annotation><annotation id="21680742_2"><infon key="gene">myosin(35007)</infon><infon key="go-term">ADP binding|GO:0043531</infon><infon key="goevidence">NONE</infon><infon key="type">GOA</infon><location offset="0" length="112"/><text>Two Drosophila Myosin Transducer Mutants with Distinct Cardiomyopathies Have Divergent ADP and Actin Affinities*</text></annotation><annotation id="21680742_3"><infon key="gene">Mhc(35007)</infon><infon key="go-term">actin binding|GO:0003779</infon><infon key="goevidence">NONE</infon><infon key="type">GOA</infon><location offset="0" length="112"/><text>Two Drosophila Myosin Transducer Mutants with Distinct Cardiomyopathies Have Divergent ADP and Actin Affinities*</text></annotation><annotation id="21680742_4"><infon key="gene">myosin(35007)</infon><infon key="go-term">actin binding|GO:0003779</infon><infon key="goevidence">NONE</infon><infon key="type">GOA</infon><location offset="0" length="112"/><text>Two Drosophila Myosin Transducer Mutants with Distinct Cardiomyopathies Have Divergent ADP and Actin Affinities*</text></annotation><annotation id="21680742_5"><infon key="gene">Mhc(35007)</infon><infon key="go-term">ADP binding|GO:0043531</infon><infon key="goevidence">NONE</infon><infon key="type">GOA</infon><location offset="0" length="112"/><text>Two Drosophila Myosin Transducer Mutants with Distinct Cardiomyopathies Have Divergent ADP and Actin Affinities*</text></annotation><annotation id="21680742_6"><infon key="gene">myosin(35007)</infon><infon key="go-term">ADP binding|GO:0043531</infon><infon key="goevidence">NONE</infon><infon key="type">GOA</infon><location offset="0" length="112"/><text>Two Drosophila Myosin Transducer Mutants with Distinct Cardiomyopathies Have Divergent ADP and Actin Affinities*</text></annotation></passage><passage><infon key="type">abstract</infon><offset>113</offset><annotation id="21680742_7"><infon key="gene">wupA(32794)</infon><infon key="go-term">skeletal muscle contraction|GO:0003009</infon><infon key="goevidence">NONE</infon><infon key="type">GOA</infon><location offset="1553" length="176"/><text>This may account for the suppression (A261T) or enhancement (G200D) of the skeletal muscle hypercontraction phenotype induced by the troponin I held-up2 mutation in Drosophila.</text></annotation><annotation id="21680742_8"><infon key="gene">held-up(3279)</infon><infon key="go-term">skeletal muscle contraction|GO:0003009</infon><infon key="goevidence">NONE</infon><infon key="type">GOA</infon><location offset="1553" length="176"/><text>This may account for the suppression (A261T) or enhancement (G200D) of the skeletal muscle hypercontraction phenotype induced by the troponin I held-up2 mutation in Drosophila.</text></annotation></passage><passage><infon key="type">paragraph</infon><offset>15328</offset><annotation id="21680742_9"><infon key="gene">hdp2(32794)</infon><infon key="go-term">ATPase activity|GO:0016887</infon><infon key="goevidence">IDA</infon><infon key="type">GOA</infon><location offset="15856" length="165"/><text>In contrast, the hdp2 enhancer mutant S1G200D showed nearly a 2-fold increase in basal Mg2+-ATPase (0.14 s-1) and no significant change in basal Ca2+-ATPase or Vmax.</text></annotation><annotation id="21680742_10"><infon key="gene">wupA(32794)</infon><infon key="go-term">ATPase activity|GO:0016887</infon><infon key="goevidence">IDA</infon><infon key="type">GOA</infon><location offset="15856" length="165"/><text>In contrast, the hdp2 enhancer mutant S1G200D showed nearly a 2-fold increase in basal Mg2+-ATPase (0.14 s-1) and no significant change in basal Ca2+-ATPase or Vmax.</text></annotation><annotation id="21680742_11"><infon key="gene">Mhc(35007)</infon><infon key="go-term">ATPase activity|GO:0016887</infon><infon key="goevidence">IGI</infon><infon key="type">GOA</infon><location offset="15856" length="165"/><text>In contrast, the hdp2 enhancer mutant S1G200D showed nearly a 2-fold increase in basal Mg2+-ATPase (0.14 s-1) and no significant change in basal Ca2+-ATPase or Vmax.</text></annotation><annotation id="21680742_12"><infon key="gene">Mhc(35007)</infon><infon key="go-term">ATPase activity|GO:0016887</infon><infon key="goevidence">IDA</infon><infon key="type">GOA</infon><location offset="15328" length="307"/><location offset="15784" length="72"/><text>The basal and actin-activated Mg2+-ATPase activities of wild-type myosin S1 and the two point mutants (S1A261T and S1G200D) were measured (Fig. 2), and the results are summarized in Table 2. The TnI hdp2 suppressor mutant S1A261T showed a more than 2-fold reduction in basal Mg2+-ATPase activity (0.04 s-1), 54 s-1, respectively) (difference significance at &lt;0.001 in each case). </text></annotation><annotation id="21680742_13"><infon key="gene">hdp2(32794)</infon><infon key="go-term">ATPase activity|GO:0016887</infon><infon key="goevidence">IDA</infon><infon key="type">GOA</infon><location offset="15519" length="116"/><location offset="15784" length="72"/><text>The TnI hdp2 suppressor mutant S1A261T showed a more than 2-fold reduction in basal Mg2+-ATPase activity (0.04 s-1), 54 s-1, respectively) (difference significance at &lt;0.001 in each case). </text></annotation><annotation id="21680742_14"><infon key="gene">wupA(32794)</infon><infon key="go-term">ATPase activity|GO:0016887</infon><infon key="goevidence">IDA</infon><infon key="type">GOA</infon><location offset="15519" length="116"/><location offset="15784" length="72"/><text>The TnI hdp2 suppressor mutant S1A261T showed a more than 2-fold reduction in basal Mg2+-ATPase activity (0.04 s-1), 54 s-1, respectively) (difference significance at &lt;0.001 in each case). </text></annotation><annotation id="21680742_15"><infon key="gene">Mhc(35007)</infon><infon key="go-term">ATPase activity|GO:0016887</infon><infon key="goevidence">IGI</infon><infon key="type">GOA</infon><location offset="15519" length="116"/><location offset="15784" length="72"/><text>The TnI hdp2 suppressor mutant S1A261T showed a more than 2-fold reduction in basal Mg2+-ATPase activity (0.04 s-1), 54 s-1, respectively) (difference significance at &lt;0.001 in each case). </text></annotation></passage><passage><infon key="type">paragraph</infon><offset>31658</offset><annotation id="21680742_16"><infon key="gene">Mhc(35007)</infon><infon key="go-term">skeletal muscle contraction|GO:0003009</infon><infon key="goevidence">IGI</infon><infon key="type">GOA</infon><location offset="31658" length="376"/><text>We investigated the steady-state and transient kinetics of two transducer mutant myosin S1 fragments that 1) yield normal morphology (A261T) or hypercontraction (G200D) in the IFM (2, 8); 2) can suppress (A261T) or enhance (G200D) the hypercontraction phenotype caused by a troponin I defect (TnI-A116V); and 3) can also induce specific phenotypes in the Drosophila heart (7).</text></annotation></passage></document></collection>
